Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,022,000 | 7,932,000 | 3,396,800 | 4,433,800 | 4,631,300 |
| Depreciation Amortization | 2,576,000 | 1,631,000 | 1,988,200 | 2,268,400 | 1,708,100 |
| Income taxes - deferred | 1,821,000 | 530,000 | -1,781,900 | -530,200 | 9,000 |
| Accounts receivable | 165,000 | -889,000 | -290,700 | -709,300 | 345,900 |
| Accounts payable and accrued liabilities | -45,000 | N/A | 117,700 | 16,400 | 63,600 |
| Other Working Capital | -2,703,000 | -3,983,000 | 1,355,900 | -250,500 | 1,671,800 |
| Other Operating Activity | -11,444,000 | 1,351,000 | 2,213,200 | 1,536,600 | -821,200 |
| Operating Cash Flow | $3,392,000 | $6,572,000 | $6,999,200 | $6,765,200 | $7,608,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,871,000 | -901,000 | 727,500 | -3,447,500 | 3,673,000 |
| PPE Investments | -1,461,000 | -1,298,000 | -1,011,000 | -980,200 | -1,402,700 |
| Net Acquisitions | -12,973,000 | N/A | -1,135,900 | -404,900 | N/A |
| Other Investing Activity | 9,719,000 | 365,000 | -1,390,600 | -51,100 | -3,100 |
| Investing Cash Flow | $3,156,000 | $-1,834,000 | $-2,810,000 | $-4,883,700 | $2,267,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,422,000 | 1,860,000 | 11,400 | -1,522,800 | 1,296,200 |
| Debt Issued | 4,228,000 | N/A | N/A | 755,100 | 1,000,000 |
| Debt Repayment | -25,000 | -1,392,000 | -1,195,300 | -506,200 | -1,014,900 |
| Common Stock Issued | 186,000 | 102,000 | 898,600 | 369,900 | 136,500 |
| Common Stock Repurchased | 0 | -2,725,000 | -1,429,700 | -1,002,300 | -1,015,300 |
| Dividend Paid | -3,479,000 | -3,401,000 | -3,428,100 | -3,322,600 | -3,349,800 |
| Other Financing Activity | -126,000 | 33,000 | 277,000 | -375,300 | -93,100 |
| Financing Cash Flow | $-1,638,000 | $-5,523,000 | $-4,866,100 | $-5,604,200 | $-3,040,400 |
| Exchange Rate Effect | 33,000 | -183,000 | 98,300 | 52,100 | -128,800 |
| Beginning Cash Position | 4,368,000 | 5,336,000 | 5,914,700 | 9,585,300 | 2,878,800 |
| End Cash Position | 9,311,000 | 4,368,000 | 5,336,100 | 5,914,700 | 9,585,300 |
| Net Cash Flow | $4,943,000 | $-968,000 | $-578,600 | $-3,670,600 | $6,706,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,392,000 | 6,572,000 | 6,999,200 | 6,765,200 | 7,608,500 |
| Capital Expenditure | -1,461,000 | -1,298,000 | -1,011,000 | -980,200 | -1,402,700 |
| Free Cash Flow | 1,931,000 | 5,274,000 | 5,988,200 | 5,785,000 | 6,205,800 |